iRadimed (iRadimed) LT-Debt-to-Total-Asset : 0.02 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is iRadimed LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. iRadimed's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.02.

iRadimed's long-term debt to total assets ratio declined from Mar. 2023 (0.03) to Mar. 2024 (0.02). It may suggest that iRadimed is progressively becoming less dependent on debt to grow their business.

iRadimed LT-Debt-to-Total-Asset Historical Data

The historical data trend for iRadimed's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed LT-Debt-to-Total-Asset Chart

iRadimed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.04

0.03

0.02

iRadimed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.02	0.02	0.02	0.02

iRadimed LT-Debt-to-Total-Asset Calculation

iRadimed's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	1.615	/	92.156
	=	0.02

iRadimed's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1.52	/	88.014
	=	0.02

iRadimed (NAS:IRMD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

iRadimed LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of iRadimed's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

iRadimed (iRadimed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (NAS:IRMD) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

46K:Germany

Address

1025 Willa Springs Drive, Winter Springs, FL, USA, 32708

Website

https://www.iradimed.com

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.

Executives

Roger E. Susi	director, 10 percent owner, officer: CEO, President, Chairman	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
James B Hawkins	director	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Anthony Vuoto	director
Monty K Allen	director
Hilda Frederique Scharen-guivel	director	440 PALM ISLAND SE, CLEARWATER BEACH FL 33767
John Glenn	officer: Chief Financial Officer	7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Christopher K. Scott	officer: CHIEF FINANCIAL OFFICER & SECR	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Brent Johnson	officer: Exec. VP. Sales & Marketing	4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588
Steven M. Nardi	officer: VP MANUFACTURING	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Louis S. Waldman	officer: CONTROLLER	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Leslie L Mcdonnell	director, officer: Chief Exec Officer & Director	1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Francis X. Casey	officer: VP OF REG AND QUAL ASSURANCE	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
John K Mccreery	officer: Chief Operating Officer	IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708
Jonathan Kennedy	director	INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Serge Novovich	director	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708